Product NDC: | 23155-108 |
Proprietary Name: | Nimodipine |
Non Proprietary Name: | Nimodipine |
Active Ingredient(s): | 30 mg/1 & nbsp; Nimodipine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 23155-108 |
Labeler Name: | Heritage |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076740 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080321 |
Package NDC: | 23155-108-30 |
Package Description: | 3 BLISTER PACK in 1 CARTON (23155-108-30) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (23155-108-11) |
NDC Code | 23155-108-30 |
Proprietary Name | Nimodipine |
Package Description | 3 BLISTER PACK in 1 CARTON (23155-108-30) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (23155-108-11) |
Product NDC | 23155-108 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Nimodipine |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20080321 |
Marketing Category Name | ANDA |
Labeler Name | Heritage |
Substance Name | NIMODIPINE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |